AHCO - AdaptHealth Corp.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 1.42B
Enterprise value 3.66B
Trailing P/E 55.58
Forward P/E 15.77
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.49
Price/book (mrq)0.66
Enterprise value/revenue 1.22
Enterprise value/EBITDA 6.66

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-40.78%
S&P500 52-week change 33.90%
52-week high 327.48
52-week low 310.00
50-day moving average 311.71
200-day moving average 317.96

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 3705.51k
Shares outstanding 5134.17M
Implied shares outstanding 6N/A
Float 863.87M
% held by insiders 123.42%
% held by institutions 185.12%
Shares short (14 May 2023) 411.64M
Short ratio (14 May 2023) 48.23
Short % of float (14 May 2023) 411.07%
Short % of shares outstanding (14 May 2023) 48.67%
Shares short (prior month 13 Apr 2023) 413.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 1.44%
Operating margin (ttm)6.50%

Management effectiveness

Return on assets (ttm)2.33%
Return on equity (ttm)2.22%

Income statement

Revenue (ttm)3.01B
Revenue per share (ttm)22.41
Quarterly revenue growth (yoy)5.40%
Gross profit (ttm)490.83M
EBITDA 563.59M
Net income avi to common (ttm)39.62M
Diluted EPS (ttm)0.19
Quarterly earnings growth (yoy)-62.40%

Balance sheet

Total cash (mrq)106.59M
Total cash per share (mrq)0.79
Total debt (mrq)2.34B
Total debt/equity (mrq)108.14
Current ratio (mrq)1.23
Book value per share (mrq)16.10

Cash flow statement

Operating cash flow (ttm)447.66M
Levered free cash flow (ttm)67.46M